Intervento alla Camera di Mauro Berruto che ringrazio immensamente. Sono ancora più motivato a fare bene e a sperare in bene. A tal dégg 👊 #Bologna5🚕

Sto punito!

Belzutifan developed by #UTSW spinoff Peloton approved for sporadic #RCC culminating 25 year KidneyCancerProgram journey starting from HIF2a gene discovery with National Cancer Institute SPORE funding bit.ly/BelzutifanAppr… based on #litespark005 led by Toni Choueiri, MD presented at ESMO - Eur. Oncology Laurence Albiges approved by

Vi presento un esempio di tassista romano (ma gli attacchi personali arrivano da tutta Italia) ossessionato dalla mia campagna di trasparenza che li sta obbligando a dichiarare di più. Tipico italiano evasore che PRETENDE di continuare a vivere col sistema di sempre, col nero

Today, we welcome Francesco Cei from Ospedale San Raffaele #urology, who will begin a research fellowship focusing on AI applications under the mentorship of Drs. Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 and #InderbirGill. Fight on! Francesco Montorsi Alessandro Larcher Giorgio Gandaglia European Association of Urology (EAU) Amer. Urol. Assn. USC Urology

Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease: hot of the press report of surveillance data from the Ospedale San Raffaele #VHL Program assessing generalizability of the MK-6482-004 trial. authors.elsevier.com/c/1iU9b9Cfv--d…

It has been an honor to present today #NureCombo trial at ASCO #GU24. Great results with neoadj nivo/abraxane followed by adj nivo in MIBC, with 38.7% ypT0N0 Andrea Necchi Ospedale San Raffaele

With a median FU up of ~5 yrs adjuvant pembro= 38% reduction in risk of death. The benefit is across subgroups (T stage etc). Subsequent therapy in 80% is relapses. The 1st +ve OS adjuvant PD1 study, making adjuvant pembro more attractive. #GU24 Toni Choueiri, MD

Truly honored to be appointed as Chair of the Scientific Committee for the European Society of Sexual Medicine. Looking forward to advancing research and knowledge in this important field! European Society for Sexual Medicine (ESSM) Uninsubria

"In your life have you seen anything like that!" Matteo Manassero 👉👈 Tiger Woods

🎉Excited to announce that we will host the 16th Annual International VHL Alliance Medical Symposium at Ospedale San Raffaele Università Vita-Salute San Raffaele 🗓️October 19-20, 2024 🗣️Leading Lights in VHL 👨‍🔬 Chaired by: Alessandro Larcher ScrittoreSalonia Othon Iliopoulos - Όθων Ηλιόπουλος ✨ Register now at shorturl.at/motK6

stereotactic ablative #RT for oligomet #RCC !! The Lancet Oncology European Association of Urology (EAU) ESTRO authors.elsevier.com/c/1j02A5EIIgPd…

Truly honoured to receive this recognition! Thanks to all the BJU International Editorial Board. Special thanks to Grant Stewart for his daily mentorship & inspiration! bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.11…

BN128: Congratulations Dr E. VENTIMIGLIA! Your manuscript : "High & Low-Power Laser Lithotripsy Achieves Similar Results: A Systematic Review…" was the Top Cited paper in J. Endourol. You will be recognized at «J.EndoUrol Editorial Board Reception» May5h (6pm) Grand Hyatt, AUA24

All’arrivo il tassametro segna 10.45 -Vorrei pagare con carta [Sbuffa] -Deve aspettare che accenda il POS… contante non ce la fate? [e intanto non blocca tassametro] -Eh no, carta grazie Continua a non bloccare il tassametro, quindi nel pos digita la cifra di 11€ Simpatia

Our team has developed a new model that accurately predicts partial nephrectomy outcomes based on patient data, tumor complexity, and surgical approach. 🔗 Check out our results: shorturl.at/cxFK9 A huge thank you to all co-authors and mentors for their contributions! 🙏

Are you a VHL Researcher? Consider abstract submissions for the 16th VHL Medical Symposium in Milan! The deadline for abstract submissions is July 3rd. Click here to register for the Symposium and submit your abstract: buff.ly/3xfgLkE

Happy to share this innovative phase I (TEM-GU) study is now active and recruiting patients with metastatic clear cell #RCC who have a disease progressing after at least 2 lines of treatment including IO and a VEGF-TKI. #Temferon is a gene therapy with hematopoietic stem cells

Let's collaborate with @IKCCorg4th on the Global #Patient #Survey on #Kidney Cancer to create education, awareness and advocacy programs for #RCC! 👉 bit.ly/ikcc2024GPS 🗓️: 15 Nov ikcc.org/global-patient… EAU-YAU Renal Cancer Working Group European Association of Urology (EAU) EAU Young Academics Michael Jewett Claudia Ungarelli